350 related articles for article (PubMed ID: 7558130)
1. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis.
Brown CR; Hunter CA; Estes RG; Beckmann E; Forman J; David C; Remington JS; McLeod R
Immunology; 1995 Jul; 85(3):419-28. PubMed ID: 7558130
[TBL] [Abstract][Full Text] [Related]
2. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice.
Suzuki Y; Joh K; Orellana MA; Conley FK; Remington JS
Immunology; 1991 Dec; 74(4):732-9. PubMed ID: 1783431
[TBL] [Abstract][Full Text] [Related]
3. MHC class I gene(s) in the D/L region but not the TNF-alpha gene determines development of toxoplasmic encephalitis in mice.
Suzuki Y; Joh K; Kwon OC; Yang Q; Conley FK; Remington JS
J Immunol; 1994 Nov; 153(10):4649-54. PubMed ID: 7963536
[TBL] [Abstract][Full Text] [Related]
4. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
Deckert-Schlüter M
Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
[TBL] [Abstract][Full Text] [Related]
5. In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain.
Johnson JJ; Roberts CW; Pope C; Roberts F; Kirisits MJ; Estes R; Mui E; Krieger T; Brown CR; Forman J; McLeod R
J Immunol; 2002 Jul; 169(2):966-73. PubMed ID: 12097403
[TBL] [Abstract][Full Text] [Related]
6. Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease.
Wang X; Kang H; Kikuchi T; Suzuki Y
Infect Immun; 2004 Aug; 72(8):4432-8. PubMed ID: 15271900
[TBL] [Abstract][Full Text] [Related]
7. TCR V beta 8+ T cells prevent development of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease.
Kang H; Liesenfeld O; Remington JS; Claflin J; Wang X; Suzuki Y
J Immunol; 2003 Apr; 170(8):4254-9. PubMed ID: 12682259
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis.
Hunter CA; Roberts CW; Alexander J
Eur J Immunol; 1992 Sep; 22(9):2317-22. PubMed ID: 1516621
[TBL] [Abstract][Full Text] [Related]
9. Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii.
Caamaño J; Tato C; Cai G; Villegas EN; Speirs K; Craig L; Alexander J; Hunter CA
J Immunol; 2000 Nov; 165(10):5720-8. PubMed ID: 11067930
[TBL] [Abstract][Full Text] [Related]
10. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.
Schlüter D; Kwok LY; Lütjen S; Soltek S; Hoffmann S; Körner H; Deckert M
J Immunol; 2003 Jun; 170(12):6172-82. PubMed ID: 12794148
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of the intracerebral and splenic cytokine mRNA production in Toxoplasma gondii-resistant and -susceptible congenic strains of mice.
Deckert-Schlüter M; Albrecht S; Hof H; Wiestler OD; Schlüter D
Immunology; 1995 Jul; 85(3):408-18. PubMed ID: 7558129
[TBL] [Abstract][Full Text] [Related]
12. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection.
Brown CR; McLeod R
J Immunol; 1990 Nov; 145(10):3438-41. PubMed ID: 2121825
[TBL] [Abstract][Full Text] [Related]
13. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.
Kang H; Remington JS; Suzuki Y
J Immunol; 2000 Mar; 164(5):2629-34. PubMed ID: 10679102
[TBL] [Abstract][Full Text] [Related]
14. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice.
Suzuki Y; Conley FK; Remington JS
J Immunol; 1989 Sep; 143(6):2045-50. PubMed ID: 2506275
[TBL] [Abstract][Full Text] [Related]
15. Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice.
Blackwell JM; Roberts CW; Alexander J
Parasite Immunol; 1993 Jun; 15(6):317-24. PubMed ID: 8361774
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
[TBL] [Abstract][Full Text] [Related]
17. Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice.
Suzuki Y; Rani S; Liesenfeld O; Kojima T; Lim S; Nguyen TA; Dalrymple SA; Murray R; Remington JS
Infect Immun; 1997 Jun; 65(6):2339-45. PubMed ID: 9169772
[TBL] [Abstract][Full Text] [Related]
18. Effects of human class I transgenes on Toxoplasma gondii cyst formation.
Brown CR; David CS; Khare SJ; McLeod R
J Immunol; 1994 May; 152(9):4537-41. PubMed ID: 8157968
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of systemic cytokine and brain chemokine gene expression in murine toxoplasma infection.
Aviles H; Stiles J; O'Donnell P; Orshal J; Leid J; Sonnenfeld G; Monroy F
J Parasitol; 2008 Dec; 94(6):1282-8. PubMed ID: 19127964
[TBL] [Abstract][Full Text] [Related]
20. Genes, cells and cytokines in resistance against development of toxoplasmic encephalitis.
Suzuki Y
Immunobiology; 1999 Dec; 201(2):255-71. PubMed ID: 10631575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
